Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
Randomized Trial on DBS Programming Based on Biomarkers vs. Standard Monopolar Review
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether an objective, data-guided approach to programming deep brain stimulation (DBS) can improve motor outcomes in people with Parkinson's disease who undergo DBS surgery. The study includes adults aged 30 to 70 years with Parkinson's disease who are candidates for DBS. The main questions it aims to answer are: Does DBS programming based on objective markers (brain imaging and brain signals) reduce the amount of daily time patients spend in the OFF state more than conventional clinical programming? Does this programming approach improve quality of life and motor symptoms compared with standard programming? Researchers will compare conventional DBS programming based on clinical monopolar review with DBS programming guided by electrode location on neuroimaging and beta brain signals recorded from the implanted device, to see if the objective approach leads to better motor control and less OFF time. Participants will: Undergo DBS surgery using a clinically approved DBS system Be randomly assigned to one of two DBS programming strategies Wear inertial sensors at home for several days at different time points to objectively measure motor symptoms Attend scheduled clinical visits for DBS programming and motor and non-motor assessments Have adaptive DBS activated after 3 months and continue follow-up until 6 months after programming begins
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
January 27, 2026
January 1, 2026
2 years
January 21, 2026
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Daily OFF Time Assessed by Wearable Sensors
Percentage change in daily time spent in the OFF state, measured objectively using PDMonitor® inertial sensors. OFF time will be quantified from continuous 7-day recordings performed at baseline (preoperative) and at 3 months after initiation of DBS programming. The outcome reflects motor fluctuations in real-life conditions.
From baseline (preoperative 7-day recording) to 3 months after start of DBS programming
Secondary Outcomes (4)
Change in Quality of Life (PDQ-39 Total Score)
From baseline to 3 months after start of DBS programming
Change in Motor Symptoms (MDS-UPDRS Part III)
From baseline to 3 months after start of DBS programming
Change in fluctuation severity (MDS-UPDRS Part IV)
From baseline and at 3 months after initiation of DBS programming.
Change in Non-Motor Symptoms (MDS-NMS)
From baseline to 3 months after start of DBS programming
Other Outcomes (5)
Effect of Adaptive DBS on Daily OFF Time Assessed by Wearable Sensors
From 3 months to 6 months after start of DBS programming
Effect of Adaptive DBS on Quality of Life (PDQ-39 Total Score)
From 3 months to 6 months after start of DBS programming
Effect of Adaptive DBS on Motor Symptoms (MDS-UPDRS Part III)
From 3 months to 6 months after start of DBS programming
- +2 more other outcomes
Study Arms (2)
Conventional DBS Programming (Monopolar Review)
ACTIVE COMPARATORParticipants in this arm will undergo DBS programming using the conventional clinical approach based on monopolar review.
Objective-Guided DBS Programming (Imaging + Local Field Potentials)
EXPERIMENTALParticipants in this arm will undergo DBS programming guided by objective markers. Selection of stimulation contacts will be informed by postoperative anatomical reconstruction of electrode location using Brainlab Elements™ and by beta-band local field potential (LFP) activity recorded with BrainSense™ from the implanted DBS system.
Interventions
DBS programming performed using the conventional clinical monopolar review approach. Stimulation contacts and parameters are selected through systematic clinical testing based on clinician assessment of motor benefit and stimulation-related side effects, together with patient-reported symptoms. Programming does not incorporate postoperative electrode localization from neuroimaging or neurophysiological biomarkers. All participants are implanted with a CE-marked DBS system (Percept™ PC or RC with SenSight™ leads), and programming begins approximately 5 weeks after surgery following standard clinical practice. At 3 months after initial programming, Adaptive DBS is activated in all patients.
DBS programming guided by objective anatomical and neurophysiological markers. Stimulation contact selection is informed by postoperative electrode reconstruction using Brainlab Elements™ and by LFP activity recorded with BrainSense™ from the implanted DBS system. These objective data are integrated with standard clinical testing to guide programming decisions. All participants are implanted with the same CE-marked DBS system (Percept™ PC or RC with SenSight™ leads), and programming starts approximately 5 weeks after surgery, following the same schedule as the comparator arm. At 3 months after initial programming, Adaptive DBS will be activated in all patients.
Eligibility Criteria
You may qualify if:
- Age between 30 and 70 years.
- Confirmed diagnosis of idiopathic Parkinson's disease according to the MDS diagnostic criteria (Postuma et al., 2015).
- Indication for deep brain stimulation surgery based on CAPSIT-PD criteria.
You may not qualify if:
- Presence of severe surgical complications (e.g., intracranial hemorrhage, infection).
- Postoperative adverse events requiring electrode repositioning.
- Any other medical or neurological condition that could interfere with safe participation in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Related Publications (3)
Muller M, van Leeuwen MFC, Hoffmann CF, van der Gaag NA, Zutt R, van der Gaag S, Schouten AC, Contarino MF. From subthalamic local field potentials to the selection of chronic deep brain stimulation contacts in Parkinson's disease - A systematic review. Brain Stimul. 2025 Sep-Oct;18(5):1499-1510. doi: 10.1016/j.brs.2025.08.004. Epub 2025 Aug 11.
PMID: 40803531BACKGROUNDNeumann WJ, Gilron R, Little S, Tinkhauser G. Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation. Mov Disord. 2023 Jun;38(6):937-948. doi: 10.1002/mds.29415. Epub 2023 May 6.
PMID: 37148553BACKGROUNDShah A, Nguyen TK, Peterman K, Khawaldeh S, Debove I, Shah SA, Torrecillos F, Tan H, Pogosyan A, Lachenmayer ML, Michelis J, Brown P, Pollo C, Krack P, Nowacki A, Tinkhauser G. Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease. Neuromodulation. 2023 Feb;26(2):320-332. doi: 10.1016/j.neurom.2022.01.017. Epub 2022 Feb 24.
PMID: 35219571BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
January 21, 2026
First Posted
January 27, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available. De-identified data may be shared upon reasonable request with the study investigators, subject to approval of a methodologically sound proposal, institutional review board approval as applicable, and execution of a data use agreement.